Benzathine penicillin G once-every-3-week prophylaxis for recurrent erysipelas a retrospective study of 132 patients.

about

Benzathine penicillin G once-every-3-week prophylaxis for recurrent erysipelas a retrospective study of 132 patients.

Item

http://www.wikidata.org/entity/Q53613429

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Benzathine penicillin G once-e ...... pective study of 132 patients.

@en

Benzathine penicillin G once-e ...... pective study of 132 patients.

@nl

type

Item

label

Benzathine penicillin G once-e ...... pective study of 132 patients.

@en

Benzathine penicillin G once-e ...... pective study of 132 patients.

@nl

prefLabel

Benzathine penicillin G once-e ...... pective study of 132 patients.

@en

Benzathine penicillin G once-e ...... pective study of 132 patients.

@nl

P1476

Benzathine penicillin G once-e ...... pective study of 132 patients.

@en

P2093

Filip Rob

http://www.w3.org/2001/XMLSchema#string

Jana Hercogová

http://www.w3.org/2001/XMLSchema#string

P2860

Patient non-compliance with paper diaries

A systematic review of the associations between dose regimens and medication compliance.

Risk factors for erysipelas of the leg (cellulitis): case-control study.

Antibiotic prophylaxis for preventing recurrent cellulitis: a systematic review and meta-analysis.

Clinical practice. Cellulitis.

Penicillin concentrations after increased doses of benzathine penicillin G for prevention of secondary rheumatic fever

Prophylactic antibiotics for the prevention of cellulitis (erysipelas) of the leg: results of the UK Dermatology Clinical Trials Network's PATCH II trial.

Self-reported utilization of health care services: improving measurement and accuracy.

Oedema as a risk factor for multiple episodes of cellulitis/erysipelas of the lower leg: a series with community follow-up.

Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care.

P304

39-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/09546634.2017.1329507

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28489486

http://www.w3.org/2001/XMLSchema#string